NO983438L - Forbedrede konsentrerte injeksjons- og infusjonsl°sninger for intravasal anvendelse - Google Patents
Forbedrede konsentrerte injeksjons- og infusjonsl°sninger for intravasal anvendelseInfo
- Publication number
- NO983438L NO983438L NO983438A NO983438A NO983438L NO 983438 L NO983438 L NO 983438L NO 983438 A NO983438 A NO 983438A NO 983438 A NO983438 A NO 983438A NO 983438 L NO983438 L NO 983438L
- Authority
- NO
- Norway
- Prior art keywords
- infusion solutions
- intravasal
- concentrated injection
- improved concentrated
- injection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19604095 | 1996-01-25 | ||
PCT/DE1997/000170 WO1997026862A2 (fr) | 1996-01-25 | 1997-01-27 | Solutions concentrees ameliorees pour injection et perfusion a administrer par voie intraveineuse |
Publications (2)
Publication Number | Publication Date |
---|---|
NO983438D0 NO983438D0 (no) | 1998-07-24 |
NO983438L true NO983438L (no) | 1998-09-18 |
Family
ID=7784538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO983438A NO983438L (no) | 1996-01-25 | 1998-07-24 | Forbedrede konsentrerte injeksjons- og infusjonsl°sninger for intravasal anvendelse |
Country Status (21)
Country | Link |
---|---|
US (1) | US6638913B1 (fr) |
EP (1) | EP0876140B1 (fr) |
JP (1) | JP2000505789A (fr) |
KR (1) | KR100505772B1 (fr) |
CN (1) | CN1209751A (fr) |
AT (1) | ATE251893T1 (fr) |
AU (1) | AU2150497A (fr) |
BG (1) | BG62913B1 (fr) |
BR (1) | BR9707081A (fr) |
CA (1) | CA2244209C (fr) |
CZ (1) | CZ234898A3 (fr) |
DE (2) | DE59710863D1 (fr) |
DK (1) | DK0876140T3 (fr) |
ES (1) | ES2208884T3 (fr) |
HU (1) | HUP9901355A3 (fr) |
IL (1) | IL124676A0 (fr) |
NO (1) | NO983438L (fr) |
PL (1) | PL328199A1 (fr) |
PT (1) | PT876140E (fr) |
SK (1) | SK101398A3 (fr) |
WO (1) | WO1997026862A2 (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
DE69828615T2 (de) * | 1997-10-31 | 2005-12-01 | Walter Reed Army Institute Of Research | Verwendung von inhibitoren der komplementaktivierung zur herstellung eines medikaments zur inhibierung von nebenwirkungen von pharmazeutischen zusammensetzungen, die amphiphile träger oder wirkstoffträger moleküle enthalten |
AU751772C (en) | 1998-04-01 | 2006-09-07 | Correvio International Sàrl | Aminocyclohexyl ether compounds and uses thereof |
US7057053B2 (en) | 2000-10-06 | 2006-06-06 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
US7524879B2 (en) | 2000-10-06 | 2009-04-28 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
DE60139944D1 (de) | 2000-10-12 | 2009-10-29 | Genentech Inc | Niederviskose konzentrierte proteinformulierungen |
US8703126B2 (en) | 2000-10-12 | 2014-04-22 | Genentech, Inc. | Reduced-viscosity concentrated protein formulations |
DE10115740A1 (de) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
US20020169112A1 (en) * | 2001-05-08 | 2002-11-14 | Luc Montagnier | Combined treatments and methods for treatment of mycoplasma and mycoplasma-like organism infections |
DE10244847A1 (de) * | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
US20070099983A1 (en) | 2003-05-02 | 2007-05-03 | Cardiome Pharma Corp. | Aminocyclohexyl ether compounds and uses thereof |
US7345087B2 (en) | 2003-10-31 | 2008-03-18 | Cardiome Pharma Corp. | Aminocyclohexyl ether compounds and uses thereof |
WO2005113011A2 (fr) | 2004-04-01 | 2005-12-01 | Cardiome Pharma Corp. | Promedicaments de composes modulant les canaux ioniques et leurs utilisations |
US8058304B2 (en) | 2004-04-01 | 2011-11-15 | Cardiome Pharma Corp. | Merged ion channel modulating compounds and uses thereof |
EP1868598B1 (fr) | 2004-11-08 | 2014-04-23 | Cardiome Pharma Corp. | Schemas posologiques pour modulateurs de canaux ioniques pour le traitement de la fibrillation auriculaire aigue chez l'homme |
US20060270708A1 (en) * | 2005-05-25 | 2006-11-30 | Navinta Llc | Novel process for preparation of isotonic aqueous injection of ropivacaine |
EP1897535A1 (fr) * | 2006-08-30 | 2008-03-12 | Dirinco AG | Liquide substitue pour haemoflitration |
US20090239894A1 (en) * | 2008-03-20 | 2009-09-24 | Bjorn Schurad | Stabilized aqueous solutions of ergoline compounds |
EP2403874A1 (fr) | 2009-03-06 | 2012-01-11 | Genentech, Inc. | Formulation d'anticorps |
US10634741B2 (en) | 2009-12-04 | 2020-04-28 | Endomagnetics Ltd. | Magnetic probe apparatus |
US9427186B2 (en) * | 2009-12-04 | 2016-08-30 | Endomagnetics Ltd. | Magnetic probe apparatus |
CA3101298A1 (fr) | 2010-03-01 | 2011-09-09 | Bayer Healthcare Llc | Optimisation d'anticorps monoclonaux diriges contre l'inhibiteur de la voie du facteur tissulaire (tfpi) |
CN102319258B (zh) * | 2011-08-04 | 2012-10-31 | 山西诺成制药有限公司 | 一种5%葡萄糖置换液及其制备方法 |
US8613919B1 (en) | 2012-08-31 | 2013-12-24 | Bayer Healthcare, Llc | High concentration antibody and protein formulations |
US9592297B2 (en) | 2012-08-31 | 2017-03-14 | Bayer Healthcare Llc | Antibody and protein formulations |
US9808539B2 (en) | 2013-03-11 | 2017-11-07 | Endomagnetics Ltd. | Hypoosmotic solutions for lymph node detection |
US9239314B2 (en) | 2013-03-13 | 2016-01-19 | Endomagnetics Ltd. | Magnetic detector |
US9234877B2 (en) | 2013-03-13 | 2016-01-12 | Endomagnetics Ltd. | Magnetic detector |
BR112015024564A2 (pt) * | 2013-03-27 | 2017-07-18 | Ge Healthcare As | solução de excipiente aquosa, conjunto, e, métodos para diluição de uma composição diagnóstica, para produzir uma solução de excipiente aquosa, e de diagnóstico e detecção de imagem |
JP6821665B2 (ja) | 2015-06-04 | 2021-01-27 | エンドマグネティクス リミテッド | 磁気マーカ |
JP7465814B2 (ja) * | 2018-04-16 | 2024-04-11 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 高濃度タンパク質製剤の粘度低下 |
CN110327292A (zh) * | 2019-08-11 | 2019-10-15 | 天津乾丰瑞科技有限公司 | 一种盐酸法舒地尔注射制剂及其制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE754523A (fr) * | 1969-08-06 | 1971-02-08 | Beecham Group Ltd | Vaccins |
BE877443A (fr) * | 1978-07-04 | 1980-01-03 | Nyegaard & Co As | Procede de preparation d'unesolution tamponnee d'une substance de contraste pour rayons x |
JPS58500563A (ja) * | 1981-04-27 | 1983-04-14 | バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド | グルコ−ス、アミノ酸およびインシユリンを含む透析液 |
US4663166A (en) * | 1984-06-22 | 1987-05-05 | Veech Richard L | Electrolyte solutions and in vivo use thereof |
IE60901B1 (en) * | 1986-08-21 | 1994-08-24 | Vestar Inc | Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics |
US5096885A (en) * | 1988-04-15 | 1992-03-17 | Genentech, Inc. | Human growth hormone formulation |
GB8906130D0 (en) * | 1989-03-17 | 1989-05-04 | Nycomed As | Compositions |
JPH0341033A (ja) * | 1989-07-07 | 1991-02-21 | Kyowa Hakko Kogyo Co Ltd | 安定なモチリン類含有製剤 |
EP0437662B1 (fr) | 1990-01-18 | 1994-09-14 | Cereria Amos Sgarbi S.P.A. | Lampe de tombeau |
GB9020091D0 (en) * | 1990-09-14 | 1990-10-24 | Nycomed As | Contrast media |
DE4135193C1 (fr) * | 1991-10-22 | 1993-03-11 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | |
IT1256248B (it) * | 1992-12-24 | 1995-11-29 | Bracco Spa | Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x |
WO1995026331A1 (fr) * | 1994-03-25 | 1995-10-05 | Centro Investigacion Justesa Imagen, S.A. | Nouveaux dimeres iodes non-ioniques, utiles en tant qu'agents de contraste aux rayons x, procede de preparation, et compositions pharmaceutiques les contenant |
DE4446694A1 (de) * | 1994-12-09 | 1996-06-13 | Schering Ag | Verwendung von Zusätzen zu Kontrastmitteln zur Verbesserung der Bildgebung |
-
1997
- 1997-01-27 CA CA002244209A patent/CA2244209C/fr not_active Expired - Fee Related
- 1997-01-27 BR BR9707081A patent/BR9707081A/pt not_active IP Right Cessation
- 1997-01-27 IL IL12467697A patent/IL124676A0/xx unknown
- 1997-01-27 KR KR10-1998-0705697A patent/KR100505772B1/ko not_active IP Right Cessation
- 1997-01-27 HU HU9901355A patent/HUP9901355A3/hu unknown
- 1997-01-27 JP JP9526441A patent/JP2000505789A/ja not_active Ceased
- 1997-01-27 DE DE59710863T patent/DE59710863D1/de not_active Expired - Fee Related
- 1997-01-27 CN CN97191871A patent/CN1209751A/zh active Pending
- 1997-01-27 DK DK97914098T patent/DK0876140T3/da active
- 1997-01-27 CZ CZ982348A patent/CZ234898A3/cs unknown
- 1997-01-27 AT AT97914098T patent/ATE251893T1/de not_active IP Right Cessation
- 1997-01-27 AU AU21504/97A patent/AU2150497A/en not_active Abandoned
- 1997-01-27 SK SK1013-98A patent/SK101398A3/sk unknown
- 1997-01-27 EP EP97914098A patent/EP0876140B1/fr not_active Expired - Lifetime
- 1997-01-27 PT PT97914098T patent/PT876140E/pt unknown
- 1997-01-27 PL PL97328199A patent/PL328199A1/xx unknown
- 1997-01-27 ES ES97914098T patent/ES2208884T3/es not_active Expired - Lifetime
- 1997-01-27 DE DE19703816A patent/DE19703816A1/de not_active Withdrawn
- 1997-01-27 WO PCT/DE1997/000170 patent/WO1997026862A2/fr not_active Application Discontinuation
-
1998
- 1998-07-21 BG BG102644A patent/BG62913B1/bg unknown
- 1998-07-24 NO NO983438A patent/NO983438L/no not_active Application Discontinuation
-
2000
- 2000-02-14 US US09/504,108 patent/US6638913B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE19703816A1 (de) | 1997-08-07 |
KR19990081979A (ko) | 1999-11-15 |
WO1997026862A3 (fr) | 1997-10-23 |
CA2244209C (fr) | 2007-10-23 |
PT876140E (pt) | 2004-02-27 |
WO1997026862A2 (fr) | 1997-07-31 |
HUP9901355A3 (en) | 2000-06-28 |
US6638913B1 (en) | 2003-10-28 |
PL328199A1 (en) | 1999-01-18 |
HUP9901355A2 (hu) | 1999-08-30 |
CN1209751A (zh) | 1999-03-03 |
BG62913B1 (bg) | 2000-11-30 |
BG102644A (en) | 1999-06-30 |
EP0876140B1 (fr) | 2003-10-15 |
AU2150497A (en) | 1997-08-20 |
DE59710863D1 (de) | 2003-11-20 |
BR9707081A (pt) | 1999-05-25 |
EP0876140A2 (fr) | 1998-11-11 |
ATE251893T1 (de) | 2003-11-15 |
JP2000505789A (ja) | 2000-05-16 |
ES2208884T3 (es) | 2004-06-16 |
CZ234898A3 (cs) | 1998-11-11 |
CA2244209A1 (fr) | 1997-07-31 |
IL124676A0 (en) | 1998-12-06 |
SK101398A3 (en) | 1998-12-02 |
KR100505772B1 (ko) | 2005-10-25 |
DK0876140T3 (da) | 2003-12-15 |
NO983438D0 (no) | 1998-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO983438L (no) | Forbedrede konsentrerte injeksjons- og infusjonsl°sninger for intravasal anvendelse | |
EA200200105A1 (ru) | СОЕДИНЕНИЯ, МОДУЛИРУЮЩИЕ АКТИВНОСТЬ PPARγ; | |
AU1718400A (en) | Method for treating pain | |
TR200000481T2 (tr) | N-Alkonoilfenilalenin türevleri. | |
MY133569A (en) | Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors | |
AU1676200A (en) | Polyhydroxylated heterocyclic derivatives as anti-coagulants | |
AP9901478A0 (en) | Compounds for the treatment of ischemia. | |
ES2186874T3 (es) | Analogos de m-amidinofenilo como inhibidores del factor xa. | |
ATE216879T1 (de) | Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs | |
UY25712A1 (es) | Benzamidas sustituidas y su aplicación en medicamentos | |
EA199900362A1 (ru) | Новые соединения, полезные для использования в качестве нейрозащитных средств | |
TR200100455T2 (tr) | Nimesulid içeren topikal farmasötik bileşimler | |
AU3052799A (en) | Pharmaceutical compositions comprising erythropoietin for treatment of cancer | |
ATE253827T1 (de) | Fungizide zusammensetzung | |
NO20003758L (no) | Trekonserveringsmidler | |
DK0896532T3 (da) | Acylurinstofforbindelser til behandling af coccidioidomycose i varmblodede dyr | |
EA199900579A1 (ru) | Применение ингибиторов комт для производства лекарственного средства для профилактики сосудистых дисфункций при диабете | |
ATE165594T1 (de) | Triarylethylenderivate zur therapeutischen verwendung | |
EE200100287A (et) | Puidukaitsevahendite lahused | |
EA199800819A1 (ru) | Способ лечения биполярного расстройства | |
SE9901469L (sv) | Träbevarande behandling | |
MY106261A (en) | Anti-inflammatory 1-heteroaryl oxindole-3-carboxamides. | |
ES2113647T3 (es) | Composicion. | |
EA199900959A1 (ru) | Способы снижения содержания фибриногена | |
DE69431118D1 (de) | Fungizide, hautkosmetishe zusammensetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |